Asston Pharmaceuticals Limited (BOM:544445)

India flag India · Delayed Price · Currency is INR
83.80
-0.69 (-0.82%)
At close: Jan 19, 2026
-29.58%
Market Cap726.16M
Revenue (ttm)244.84M
Net Income (ttm)24.58M
Shares Out8.51M
EPS (ttm)3.76
PE Ratio22.68
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,000
Average Volume13,200
Open84.49
Previous Close84.49
Day's Range83.80 - 84.49
52-Week Range75.21 - 126.00
Betan/a
RSI48.60
Earnings DateJan 5, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544445
Full Company Profile

Financial Performance

In 2024, Asston Pharmaceuticals's revenue was 250.39 million, an increase of 60.65% compared to the previous year's 155.86 million. Earnings were 43.25 million, an increase of 217.95%.

Financial Statements